These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33572150)

  • 1. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.
    Luu K; Patwardhan MV; Zeng Q; Wickström SL; Lundqvist A; Schwarz H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33572150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD137 expression by viral genes reduces T cell costimulation.
    Wu M; Wong HY; Lin JL; Moliner A; Schwarz H
    J Cell Physiol; 2019 Nov; 234(11):21076-21088. PubMed ID: 31025383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137
    Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG
    J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    Wong HY; Schwarz H
    J Autoimmun; 2020 Aug; 112():102499. PubMed ID: 32505443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.
    Tang Q; Koh LK; Jiang D; Schwarz H
    Aging (Albany NY); 2013 Sep; 5(9):643-52. PubMed ID: 23945137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
    Mak A; Schwarz H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages.
    Xu Y; Yan Y; Geng T; Wang C; Xu Y; Yang P; Yan J
    J Cardiovasc Pharmacol; 2020 Feb; 75(2):148-154. PubMed ID: 31651672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
    Ho WT; Pang WL; Chong SM; Castella A; Al-Salam S; Tan TE; Moh MC; Koh LK; Gan SU; Cheng CK; Schwarz H
    Cancer Res; 2013 Jan; 73(2):652-61. PubMed ID: 23204227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trogocytic CD137 transfer causes an internalization of CD137 ligand on murine APCs leading to reduced T cell costimulation.
    Shao Z; Harfuddin Z; Pang WL; Nickles E; Koh LK; Schwarz H
    J Leukoc Biol; 2015 May; 97(5):909-919. PubMed ID: 25765680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor.
    Kang SW; Cho HR; Kwon B
    Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
    Prasad M; Ponnalagu S; Zeng Q; Luu K; Lang SM; Wong HY; Cheng MS; Wu M; Mallilankaraman K; Sobota RM; Lim YT; Wang LC; Goh CK; Tay KXJ; Loh KS; Wang CI; Lee WH; Goh BC; Lim CM; Schwarz H
    Cancer Immunol Immunother; 2022 Nov; 71(11):2583-2596. PubMed ID: 35299256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.
    Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B
    Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
    Yeo YA; Martínez Gómez JM; Croxford JL; Gasser S; Ling EA; Schwarz H
    J Neuroinflammation; 2012 Jul; 9():173. PubMed ID: 22799524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.
    Li Y; Yan J; Wu C; Wang Z; Yuan W; Wang D
    PLoS One; 2014; 9(2):e88563. PubMed ID: 24520398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of CD137-CD137L signaling on secretion of mouse vascular smooth muscle cells-derived exosomes: role of Rab7 pathway].
    He Y; Cui XG; Li B; Wang N; Xu Y; Xu Y; Geng TX; Yan JC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):829-835. PubMed ID: 31648466
    [No Abstract]   [Full Text] [Related]  

  • 16. The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.
    Choi BK; Lee HW
    Front Immunol; 2020; 11():553715. PubMed ID: 33362756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes.
    Rojas M; Heuer LS; Zhang W; Chen YG; Ridgway WM
    Front Immunol; 2022; 13():918837. PubMed ID: 35935980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15- and IL-21-Driven NK Cell Proliferation.
    Vidard L; Dureuil C; Baudhuin J; Vescovi L; Durand L; Sierra V; Parmantier E
    J Immunol; 2019 Aug; 203(3):676-685. PubMed ID: 31201235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and mouse CD137 have predominantly different binding CRDs to their respective ligands.
    Yi L; Zhao Y; Wang X; Dai M; Hellström KE; Hellström I; Zhang H
    PLoS One; 2014; 9(1):e86337. PubMed ID: 24466035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
    Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
    Front Immunol; 2018; 9():199. PubMed ID: 29467769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.